Clinical Trial Update: A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating an investigational pain medicine for postherpetic neuralgia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Investigational pain medicine

Snippet

Sponsor: Pfizer | Conditions: Postherpetic Neuralgia | Phase 2 | Status: WITHDRAWN